REQUEST A DEMO
Total
USD $0.00
Search more companies

Xiang Xue Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Soft Drink and Ice Manufacturing | Medical Equipment and Supplies Manufacturing
Full name: Xiang Xue Pharmaceutical Co., Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The company is a stock limited restructured from Guanghzou Luogang Pharmaceutical Co.,Ltd. On December 16, 1997, Kunlun Investment, Luogang Economic Development Corporation, Kunlun Industry and Trade, Luogang Urban Construction Company and Kunlun technology sighed “Sponsor Agreement” on establishing Guanghzou Xiangxue Pharmaceutical Co.,Ltd. Luogang Pharmaceutical Factory was restructured into Guanghzou Xiangxue Pharmaceutical Co.,Ltd according to No. (97) 812 Document issued by Yangzheng Accountant Agency. On December 29, 1997, the company registered in Guanghzou Administration of Industry and Commerce and received a Business License for Enterprise’s Legal Person with Registration No. 63321088-4. On June 28, 2002, the company transferred its registration in Guangdong Provincial Administration of Industry and Commerce and received a new Business License for Enterprise’s Legal Person with Registration No. 4400001010002. On June 30, 2002, Guangdong Provincial People’s Governent’s “Approval on Establishing Guanghzou Xiangxue Pharmaceutical Co.,Ltd” ( No. [2003]201 Document) recognized its establishment and on December 11, 2007, its registration number was changed into 440000000024049 according to “Notice on Distributing and Implementing ‘Rule of Industry and Commerce Administration Registration Numbers’ (No. [2007] 79 Document) issued by State Administration for Industry and Commerce.

Headquarters
No. 2, Jinfengyuan Road, Science City, Guangzhou Economic and Technological Development Zone, Luogang District, Guangzhou City, Guangdong Province
Guangzhou; Guangdong; Postal Code: 510663

Contact Details: Purchase the Xiang Xue Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.xphcn.com

Basic Information
Total Employees:
Purchase the Xiang Xue Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Xiang Xue Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Xiang Xue Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Xiang Xue Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
December 16, 1997
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
22.59%
Purchase this report to view the information.
4.06%
Purchase this report to view the information.
0.53%
Purchase this report to view the information.
0.39%
Purchase this report to view the information.
0.35%
Subsidiaries
Anhui Huqiao Chinese Herbal Pieces Engineering Research Center Co., Ltd.
Anhui Huqiao Pharmaceutical Co., Ltd.
Axis Therareutics Limited
Company Performance
Financial values in the chart are available after Xiang Xue Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-11.26%
Total operating revenue
-10.32%
Operating profit (EBIT)
-57.02%
Net Profit (Loss) for the Period
-49.28%
Total assets
-12.33%
Total equity
-21.12%
Operating Profit Margin (ROS)
-4.43%
Net Profit Margin
-5.21%
Return on Equity (ROE)
-4.39%
Debt to Equity Ratio
8.84%
Quick Ratio
0.02%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?